IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 421 - 432 of 1434 stories.
February 19, 2014
Excipact says that Saudi Kayan Petrochemical (Al Jubail), an affiliate of Sabic, has received an Excipact certification from SGS, one of its certification bodies. The Excipact...
February 18, 2014
Aurobindo Pharma reports rise in API sales The active pharmaceutical ingredient (API) business of Aurobindo Pharma (Hyderabad, India) reports a 12.7% rise in sales in the...
February 17, 2014
Novartis announced today that it is buying CoStim Pharmaceuticals (Cambridge, MA), a privately held biotechnology company focused on harnessing the immune system to eliminate...
February 12, 2014
Cedarburg Hauser Pharmaceuticals (CHP; Grafton, WI), a contract development and manufacturing organization specializing in small molecule active pharmaceutical ingredients (APIs), says...
February 12, 2014
The active pharmaceutical ingredient (API) business of Aurobindo Pharma (Hyderabad, India) reports a 12.7% rise in sales in the company’s fiscal third quarter, ended 31 December...
February 11, 2014
The pharmaceutical services and active ingredients (PSAI) business of Dr. Reddy’s Laboratories (Hyderabad, India) reports a 29% fall in sales in the company’s fiscal third...
February 11, 2014
Cambrex (East Rutherford, NJ) reports a 79.6% fall in net profits for the fourth quarter of 2013, ended 31 December, compared with the year-ago quarter, to $8.89 million. The results...
February 11, 2014
Jazz Pharmaceuticals (Dublin), a specialty biopharmaceutical company, on Monday held a ground breaking ceremony for a €45–50 million ($60-68 million) manufacturing and...
February 11, 2014
Teva’s API business reports fall in sales The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (Petaḥ Tiqwa, Israel) reports a 19.3% fall in...
February 7, 2014
The active pharmaceutical ingredient (API) business of Ranbaxy Laboratories (Gurgaon, India) reports sales of 1.37 billion Indian rupees ($22 million) in the fourth quarter of 2013...
February 7, 2014
The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (Petaḥ Tiqwa, Israel) reports a 19.3% fall in sales in the fourth quarter of 2013, compared with...
February 5, 2014
FMC today reported fourth-quarter earnings down 73.5% year-on-year (YOY), to $27.1 million, or 20 cts/share, on sales up 24%, to $1.1 billion. Earnings were hit by $114.3 million in...
Pages: « Previous  34 35 36 37 38 39 40 41 42 [43] 44 45 46 47 48 49 50 51 52 Next »




RSS Follow us on Twitter Join us on LinkedIn Like us on Facebook Youtube channel
contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa